MBSR may help reduce the need for pharmacologic treatment of menopausal symptoms.

Adjunctive tibolone may be a treatment option for difficult-to-treat symptoms.

Study assessing women’s cognitive performance between ages 43 and 69 years.

Femoral bone mineral density decreases with increasing parity.

Visceral adiposity may have cardiovascular, metabolic, and bone health implications.

2 patients in ROSE-1 experienced return of menses.

Maintenance of adequate serum levels of 25-hydroxyvitamin-D in postmenopausal women may reduce the risk of developing metabolic syndrome.

Follow-up of an ancillary MRI study of the KEEPS randomized trial.

Outcomes with estrogen not different from placebo.

Insights from the UK Biobank imaging enhancement study.

Results from an international pooled analysis of 11 prospective studies.

Women with early menarche or menopause should be monitored carefully.

Meta-analysis shows schizophrenia symptom improvement in this population.

Risks reduced for ovarian, endometrial cancers but increased for breast, pancreatic cancers.